FundsXML

Generate EMT 4.2 FundsXML files

Control Data

Unique Document ID:

Document Generated (YYYY-MM-DDThh:mm:ss):

Content Date:

Data Supplier System Country:

Data Supplier Short Name:

Data Supplier Name:

Data Supplier Type:

Data Set Information

EMT Version:

Producer Name:

Producer LEI:

Producer Email:

File Generation Date/Time (YYYY-MM-DDThh:mm:ss):

Data Reporting Target Market:

Data Reporting Ex-Ante:

Data Reporting Ex-Post:

General Information

Instrument Code:

Codification System:

Instrument Name:

Instrument Currency:

Instrument Performance Fee:

Instrument Distribution of Cash:

General Reference Date:

Product Type:

Maturity Date:

May Be Terminated Early:

Manufacturer Name:

Manufacturer LEI:

Manufacturer Email:

Manufacturer Product Governance Process:

Guarantor Name:

Product Category Nature Germany:

Leveraged or Contingent Liability:

Target Market

Investor Type

Retail:

Professional:

Eligible Counterparty:

Knowledge and Experience

Basic Investor:

Informed Investor:

Advanced Investor:

Ability to Bear Losses

No Capital Loss:

Limited Capital Loss:

Limited Capital Loss Level (%):

No Capital Guarantee:

Loss Beyond Capital:

Risk Tolerance

PRIIPS Methodology:

UCITS Methodology:

Internal Methodology:

Client Objectives and Needs

Return Profile - Preservation:

Return Profile - Growth:

Return Profile - Income:

Recommended Holding Period:

Compatible with Clients Having ESG Preferences:

Distribution Strategy

Execution Only:

Execution with Appropriateness:

Investment Advice:

Portfolio Management:

Costs and Charges Ex-Ante

Entry Cost (%):

Exit Cost (%):

Ongoing Costs (%):

Management Fee (%):

Distribution Fee (%):

Transaction Costs (%):

Incidental Costs (%):

Reference Price:

Notional Reference Amount:

Costs Reference Date:

Costs and Charges Ex-Post

Additional Information UK

Transaction Costs Ex-Ante UK (%):

Transaction Costs Ex-Post UK (%):

Value for Money

EMT Data Reporting VFM:

Is Assessment of Value Required Under COLL:

Outcome of COLL Assessment of Value:

Outcome of PRIN Value Assessment or Review:

Other Review Related to Value and/or Charges:

Further Information:

Review Date:

Review Next Due: